"Pharmaceutics" - Google News

‘Chemical cocktail’ of pharmaceuticals found in Djibouti coastal waters - news - Mongabay

Fri, 12 Jun 2026 10:00:42 GMT

‘Chemical cocktail’ of pharmaceuticals found in Djibouti coastal waters news - Mongabay

Jazz Pharmaceuticals Provides Update on Zepzelca® (lurbinectedin) Phase 3 LAGOON Trial in Second-Line Small Cell Lung Cancer - PR Newswire

Fri, 12 Jun 2026 12:00:00 GMT

Jazz Pharmaceuticals Provides Update on Zepzelca® (lurbinectedin) Phase 3 LAGOON Trial in Second-Line Small Cell Lung Cancer PR Newswire

Is Regeneron Pharmaceuticals, Inc. (REGN) A Good Stock To Buy Now? - Yahoo Finance

Thu, 11 Jun 2026 18:21:18 GMT

Is Regeneron Pharmaceuticals, Inc. (REGN) A Good Stock To Buy Now? Yahoo Finance

Chiesi Group Completes Acquisition of KalVista Pharmaceuticals - Business Wire

Thu, 11 Jun 2026 12:41:00 GMT

Chiesi Group Completes Acquisition of KalVista Pharmaceuticals Business Wire

Adial Pharmaceuticals Announces Acquisition of Azora Therapeutics and up to $64 Million Financing - GlobeNewswire

Thu, 11 Jun 2026 15:43:51 GMT

Adial Pharmaceuticals Announces Acquisition of Azora Therapeutics and up to $64 Million Financing GlobeNewswire

Eloxx Pharmaceuticals, Inc. Announces Pricing of $66.0 Million Public Offering and Uplisting to Nasdaq - BioSpace

Tue, 09 Jun 2026 08:39:38 GMT

Eloxx Pharmaceuticals, Inc. Announces Pricing of $66.0 Million Public Offering and Uplisting to Nasdaq BioSpace

Lexicon Pharmaceuticals vs. Pfizer: Which Drugmaker Stock Is a Better Buy in 2026? - The Motley Fool

Thu, 11 Jun 2026 14:45:00 GMT

Lexicon Pharmaceuticals vs. Pfizer: Which Drugmaker Stock Is a Better Buy in 2026? The Motley Fool

Milestone Pharmaceuticals: Here Comes The Revenue Ramp (NASDAQ:MIST) - Seeking Alpha

Tue, 09 Jun 2026 19:38:58 GMT

Milestone Pharmaceuticals: Here Comes The Revenue Ramp (NASDAQ:MIST) Seeking Alpha

Biogen completes acquisition of Apellis Pharmaceuticals - Ophthalmology Times

Mon, 18 May 2026 07:00:00 GMT

Biogen completes acquisition of Apellis Pharmaceuticals Ophthalmology Times

Xenon Pharmaceuticals Inc. Rings the Opening Bell - Nasdaq

Tue, 02 Jun 2026 13:15:00 GMT

Xenon Pharmaceuticals Inc. Rings the Opening Bell Nasdaq

Is Lexicon Pharmaceuticals, Inc. (LXRX) A Good Stock To Buy Now? - Yahoo Finance

Thu, 11 Jun 2026 18:00:02 GMT

Is Lexicon Pharmaceuticals, Inc. (LXRX) A Good Stock To Buy Now? Yahoo Finance

NLS Pharmaceutics Ltd. Announces 1-for-10 Reverse Share Split and Name Change in Connection with Proposed Merger with Kadimastem - PR Newswire

Wed, 29 Oct 2025 07:00:00 GMT

NLS Pharmaceutics Ltd. Announces 1-for-10 Reverse Share Split and Name Change in Connection with Proposed Merger with Kadimastem PR Newswire

Is Vertex Pharmaceuticals Incorporated (VRTX) A Good Stock To Buy Now? - Yahoo Finance

Thu, 11 Jun 2026 17:18:41 GMT

Is Vertex Pharmaceuticals Incorporated (VRTX) A Good Stock To Buy Now? Yahoo Finance

NLS Pharmaceutics and Kadimastem Announce Completion of Material Conditions Precedent for Merger Transaction and Delisting Date of Kadimastem's Shares - PR Newswire

Wed, 29 Oct 2025 07:00:00 GMT

NLS Pharmaceutics and Kadimastem Announce Completion of Material Conditions Precedent for Merger Transaction and Delisting Date of Kadimastem's Shares PR Newswire

NLS Pharmaceutics Ltd. and Kadimastem Ltd. Announce Completion of Merger - PR Newswire

Thu, 30 Oct 2025 07:00:00 GMT

NLS Pharmaceutics Ltd. and Kadimastem Ltd. Announce Completion of Merger PR Newswire

Catalyst Pharmaceutics to Report Q1 Earnings: Is a Beat in the Cards? - Yahoo Finance

Mon, 04 May 2026 07:00:00 GMT

Catalyst Pharmaceutics to Report Q1 Earnings: Is a Beat in the Cards? Yahoo Finance

Vanda Pharmaceuticals Announces Orphan Drug Designation in Japan for Imsidolimab in Generalized Pustular Psoriasis - PR Newswire

Wed, 27 May 2026 07:00:00 GMT

Vanda Pharmaceuticals Announces Orphan Drug Designation in Japan for Imsidolimab in Generalized Pustular Psoriasis PR Newswire

NLS Pharmaceutics Shareholders Approve Merger with Kadimastem and Related Proposals at Extraordinary General Meeting - PR Newswire

Tue, 30 Sep 2025 07:00:00 GMT

NLS Pharmaceutics Shareholders Approve Merger with Kadimastem and Related Proposals at Extraordinary General Meeting PR Newswire

Armata Pharmaceuticals Secures FDA Fast Track Designation for AP-SA02 - PR Newswire

Thu, 07 May 2026 07:00:00 GMT

Armata Pharmaceuticals Secures FDA Fast Track Designation for AP-SA02 PR Newswire

Vanda Pharmaceuticals Reports First Quarter 2026 Financial Results - PR Newswire

Wed, 06 May 2026 07:00:00 GMT

Vanda Pharmaceuticals Reports First Quarter 2026 Financial Results PR Newswire

Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders | Eli Lilly and Company - investor.lilly.com

Tue, 31 Mar 2026 10:48:43 GMT

Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders | Eli Lilly and Company investor.lilly.com

International Journal of Pharmaceutics | Vol 693, 25 March 2026 - ScienceDirect.com

Wed, 25 Mar 2026 07:00:00 GMT

International Journal of Pharmaceutics | Vol 693, 25 March 2026 ScienceDirect.com

Biogen Completes Acquisition of Apellis Pharmaceuticals - Biogen

Thu, 14 May 2026 07:00:00 GMT

Biogen Completes Acquisition of Apellis Pharmaceuticals Biogen

Trump imposes tariffs on pharmaceuticals, adjusts duties on steel, other metals - Politico

Thu, 02 Apr 2026 07:00:00 GMT

Trump imposes tariffs on pharmaceuticals, adjusts duties on steel, other metals Politico

A Novel Immune-Modulating Nanodrug Enhances Liver-Targeted mRNA Delivery - ACS Publications

Fri, 13 Mar 2026 07:00:00 GMT

A Novel Immune-Modulating Nanodrug Enhances Liver-Targeted mRNA Delivery ACS Publications

NLS Pharmaceutics Expands CNS Pipeline With AEX-6xx Series Developed by Aexon Labs - PR Newswire

Thu, 30 Oct 2025 07:00:00 GMT

NLS Pharmaceutics Expands CNS Pipeline With AEX-6xx Series Developed by Aexon Labs PR Newswire

EPA flags microplastics, pharmaceuticals as contaminants in drinking water - NPR

Thu, 02 Apr 2026 07:00:00 GMT

EPA flags microplastics, pharmaceuticals as contaminants in drinking water NPR

Vanda Pharmaceuticals announces the publication of "Efficacy and Safety of Imsidolimab for Generalized Pustular Psoriasis" in NEJM Evidence - PR Newswire

Tue, 28 Apr 2026 07:00:00 GMT

Vanda Pharmaceuticals announces the publication of "Efficacy and Safety of Imsidolimab for Generalized Pustular Psoriasis" in NEJM Evidence PR Newswire

Recurrent Neural Networks Predict Future Peptide Aggregation for Drug Development - ACS Publications

Wed, 15 Oct 2025 07:00:00 GMT

Recurrent Neural Networks Predict Future Peptide Aggregation for Drug Development ACS Publications

Baker Donelson Represents Cumberland Pharmaceuticals in Strategic Transaction to Integrate Commercial Business with Apotex - Baker Donelson

Fri, 24 Apr 2026 07:00:00 GMT

Baker Donelson Represents Cumberland Pharmaceuticals in Strategic Transaction to Integrate Commercial Business with Apotex Baker Donelson

Vanda Pharmaceuticals Appoints Dr. Charles Duncan to its Board of Directors - PR Newswire

Wed, 22 Apr 2026 07:00:00 GMT

Vanda Pharmaceuticals Appoints Dr. Charles Duncan to its Board of Directors PR Newswire

Jazz Pharmaceuticals Announces First Quarter 2026 Financial Results - PR Newswire

Tue, 05 May 2026 07:00:00 GMT

Jazz Pharmaceuticals Announces First Quarter 2026 Financial Results PR Newswire

Arrowhead Pharmaceuticals Receives Positive CHMP Opinion Recommending Approval of REDEMPLO® (plozasiran) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome (FCS) in Europe - Arrowhead Pharmaceuticals, Inc.

Fri, 24 Apr 2026 07:00:00 GMT

Arrowhead Pharmaceuticals Receives Positive CHMP Opinion Recommending Approval of REDEMPLO® (plozasiran) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome (FCS) in Europe Arrowhead Pharmaceuticals, Inc.

Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences - Business Wire

Thu, 28 May 2026 07:00:00 GMT

Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences Business Wire

Kezar Life Sciences Acquired by Aurinia Pharmaceuticals - Cooley

Mon, 30 Mar 2026 07:00:00 GMT

Kezar Life Sciences Acquired by Aurinia Pharmaceuticals Cooley

Armata Pharmaceuticals Announces Structural Biology Publication in "Communications Biology" - PR Newswire

Mon, 04 May 2026 07:00:00 GMT

Armata Pharmaceuticals Announces Structural Biology Publication in "Communications Biology" PR Newswire

EPA adds microplastics, pharmaceuticals to contaminant list - Coastal Review

Mon, 13 Apr 2026 07:00:00 GMT

EPA adds microplastics, pharmaceuticals to contaminant list Coastal Review

Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results - PR Newswire

Wed, 11 Feb 2026 08:00:00 GMT

Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results PR Newswire

EPA’s Draft Sixth Contaminant Candidate List Targets Microplastics and Pharmaceuticals in Drinking Water - globalelr.com

Wed, 29 Apr 2026 07:00:00 GMT

EPA’s Draft Sixth Contaminant Candidate List Targets Microplastics and Pharmaceuticals in Drinking Water globalelr.com

EPA Begins Process to Regulate Pharmaceuticals in Drinking Water - insideenergyandenvironment.com

Wed, 06 May 2026 07:00:00 GMT

EPA Begins Process to Regulate Pharmaceuticals in Drinking Water insideenergyandenvironment.com

Global crackdown on illicit pharmaceuticals sees USD 15.5 million in seizures - Interpol

Thu, 07 May 2026 07:00:00 GMT

Global crackdown on illicit pharmaceuticals sees USD 15.5 million in seizures Interpol

Enanta Pharmaceuticals to Present at the Jefferies Global Healthcare Conference - Business Wire

Thu, 28 May 2026 07:00:00 GMT

Enanta Pharmaceuticals to Present at the Jefferies Global Healthcare Conference Business Wire

Pierre Fabre Pharmaceuticals Announces Type A Meeting Agreed with U.S. Food and Drug Administration (FDA) for Tabelecleucel Biologic License Application (BLA) - PR Newswire

Thu, 12 Mar 2026 07:00:00 GMT

Pierre Fabre Pharmaceuticals Announces Type A Meeting Agreed with U.S. Food and Drug Administration (FDA) for Tabelecleucel Biologic License Application (BLA) PR Newswire

Executive Order Imposing Section 232 Tariffs on Pharmaceuticals and Pharmaceutical Ingredients - Foley Hoag

Fri, 03 Apr 2026 07:00:00 GMT

Executive Order Imposing Section 232 Tariffs on Pharmaceuticals and Pharmaceutical Ingredients Foley Hoag

Mirum Pharmaceuticals Announces New Data from Rare Liver Disease Programs Presented at the EASL International Liver Congress 2026 - Business Wire

Sat, 30 May 2026 16:00:00 GMT

Mirum Pharmaceuticals Announces New Data from Rare Liver Disease Programs Presented at the EASL International Liver Congress 2026 Business Wire

Drawing inspiration from nature to formulate new pharmaceuticals - Purdue University - College of Agriculture

Mon, 02 Mar 2026 08:00:00 GMT

Drawing inspiration from nature to formulate new pharmaceuticals Purdue University - College of Agriculture

Citius Pharmaceuticals Announces Closing of Registered Direct Offering of $5 Million Priced At-The-Market Under Nasdaq Rules - PR Newswire

Fri, 24 Apr 2026 07:00:00 GMT

Citius Pharmaceuticals Announces Closing of Registered Direct Offering of $5 Million Priced At-The-Market Under Nasdaq Rules PR Newswire

EPA moves to designate microplastics and pharmaceuticals as contaminants in drinking water - The Guardian

Fri, 03 Apr 2026 07:00:00 GMT

EPA moves to designate microplastics and pharmaceuticals as contaminants in drinking water The Guardian

Armata Pharmaceuticals Announces First Quarter 2026 Results and Provides Corporate Update - PR Newswire

Wed, 13 May 2026 07:00:00 GMT

Armata Pharmaceuticals Announces First Quarter 2026 Results and Provides Corporate Update PR Newswire

Vanda Pharmaceuticals Announces FDA Approval of NEREUS™ (tradipitant) for the Prevention of Vomiting Induced by Motion: A Historic Scientific Milestone in the Prevention of Motion Sickness - PR Newswire

Tue, 30 Dec 2025 08:00:00 GMT

Vanda Pharmaceuticals Announces FDA Approval of NEREUS™ (tradipitant) for the Prevention of Vomiting Induced by Motion: A Historic Scientific Milestone in the Prevention of Motion Sickness PR Newswire

NLS Pharmaceutics and Kadimastem merge to form NewcelX - S-GE

Tue, 04 Nov 2025 08:00:00 GMT

NLS Pharmaceutics and Kadimastem merge to form NewcelX S-GE

Paratek Pharmaceuticals to Combine with Radius Health, Expanding Its Multi-Product Specialty Commercial Platform - Sixth Street

Wed, 18 Mar 2026 07:00:00 GMT

Paratek Pharmaceuticals to Combine with Radius Health, Expanding Its Multi-Product Specialty Commercial Platform Sixth Street

DISCO Pharmaceuticals Enters License Agreement With Amgen - Cooley

Wed, 07 Jan 2026 08:00:00 GMT

DISCO Pharmaceuticals Enters License Agreement With Amgen Cooley

Citius Pharmaceuticals Announces a Registered Direct Offering of $5 Million Priced At-The-Market Under Nasdaq Rules - PR Newswire

Fri, 24 Apr 2026 07:00:00 GMT

Citius Pharmaceuticals Announces a Registered Direct Offering of $5 Million Priced At-The-Market Under Nasdaq Rules PR Newswire

Pharmaceuticals in the Environment - UNEP - UN Environment Programme

Wed, 13 May 2026 07:00:00 GMT

Pharmaceuticals in the Environment UNEP - UN Environment Programme

Novartis Pharmaceuticals Announces $220 M Expansion in Morrisville - Wake County Government (.gov)

Mon, 04 May 2026 07:00:00 GMT

Novartis Pharmaceuticals Announces $220 M Expansion in Morrisville Wake County Government (.gov)

Recursion Pharmaceuticals Just Hit a 52-Week Low. Is This Former Nvidia Holding a Smart Buy Now? - The Motley Fool

Mon, 25 May 2026 07:00:00 GMT

Recursion Pharmaceuticals Just Hit a 52-Week Low. Is This Former Nvidia Holding a Smart Buy Now? The Motley Fool

Jazz Pharmaceuticals to Participate in Upcoming Investor Conferences - PR Newswire

Tue, 12 May 2026 07:00:00 GMT

Jazz Pharmaceuticals to Participate in Upcoming Investor Conferences PR Newswire

Armata Pharmaceuticals Receives FDA Qualified Infectious Disease Product (QIDP) Designation for AP-SA02 - PR Newswire

Mon, 23 Feb 2026 08:00:00 GMT

Armata Pharmaceuticals Receives FDA Qualified Infectious Disease Product (QIDP) Designation for AP-SA02 PR Newswire

Arrowhead Pharmaceuticals Announces FDA Approval of REDEMPLO® (plozasiran) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome (FCS) - Arrowhead Pharmaceuticals, Inc.

Tue, 18 Nov 2025 08:00:00 GMT

Arrowhead Pharmaceuticals Announces FDA Approval of REDEMPLO® (plozasiran) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome (FCS) Arrowhead Pharmaceuticals, Inc.

Vanda Pharmaceuticals Announces U.S. Commercial Availability of NEREUS™ (tradipitant), the First New Pharmacologic Treatment for People with Motion Sickness in More Than 40 Years - PR Newswire

Fri, 01 May 2026 07:00:00 GMT

Vanda Pharmaceuticals Announces U.S. Commercial Availability of NEREUS™ (tradipitant), the First New Pharmacologic Treatment for People with Motion Sickness in More Than 40 Years PR Newswire

Enzian Pharmaceutics demonstrates that its expandable fibrous dosage forms enhance the bioavailability of sparingly-soluble drugs - Business Wire

Wed, 28 Jan 2026 08:00:00 GMT

Enzian Pharmaceutics demonstrates that its expandable fibrous dosage forms enhance the bioavailability of sparingly-soluble drugs Business Wire

US agencies to monitor drinking water for microplastics, pharmaceuticals - Reuters

Fri, 03 Apr 2026 07:00:00 GMT

US agencies to monitor drinking water for microplastics, pharmaceuticals Reuters

A Look At Recursion Pharmaceuticals (RXRX) Valuation After Clinical Updates And FDA Discussions - Yahoo Finance

Fri, 08 May 2026 07:00:00 GMT

A Look At Recursion Pharmaceuticals (RXRX) Valuation After Clinical Updates And FDA Discussions Yahoo Finance

PIERRE FABRE PHARMACEUTICALS STATEMENT REGARDING RECEIPT OF COMPLETE RESPONSE LETTER FOR TABELECLEUCEL BIOLOGICS LICENSE APPLICATION FROM THE U.S. FOOD AND DRUG ADMINISTRATION - PR Newswire

Mon, 12 Jan 2026 08:00:00 GMT

PIERRE FABRE PHARMACEUTICALS STATEMENT REGARDING RECEIPT OF COMPLETE RESPONSE LETTER FOR TABELECLEUCEL BIOLOGICS LICENSE APPLICATION FROM THE U.S. FOOD AND DRUG ADMINISTRATION PR Newswire

EPA moves to designate microplastics and pharmaceuticals as contaminants in drinking water - AP News

Thu, 02 Apr 2026 07:00:00 GMT

EPA moves to designate microplastics and pharmaceuticals as contaminants in drinking water AP News

Ironwood Pharmaceuticals to Participate in The Citizens Life Sciences Conference - Ironwood Pharmaceuticals

Wed, 04 Mar 2026 08:00:00 GMT

Ironwood Pharmaceuticals to Participate in The Citizens Life Sciences Conference Ironwood Pharmaceuticals

[Hikma Pharmaceuticals v. Amarin Pharma] Oral Argument - C-SPAN

Wed, 29 Apr 2026 07:00:00 GMT

[Hikma Pharmaceuticals v. Amarin Pharma] Oral Argument C-SPAN

Vanda Pharmaceuticals Announces Initiation of The Thetis Study, a Clinical Trial of NEREUS™ for the Prevention of Vomiting Induced by GLP-1 Receptor Agonists - PR Newswire

Wed, 08 Apr 2026 07:00:00 GMT

Vanda Pharmaceuticals Announces Initiation of The Thetis Study, a Clinical Trial of NEREUS™ for the Prevention of Vomiting Induced by GLP-1 Receptor Agonists PR Newswire

SciNeuro Pharmaceuticals Announces $53 Million Financing to Further Advance Pipeline of Therapies for Neurodegenerative Diseases and Appointment of Chief Financial Officer - PR Newswire

Thu, 04 Dec 2025 08:00:00 GMT

SciNeuro Pharmaceuticals Announces $53 Million Financing to Further Advance Pipeline of Therapies for Neurodegenerative Diseases and Appointment of Chief Financial Officer PR Newswire

Pierre Fabre Pharmaceuticals Submits Type A Meeting Request to U.S. Food and Drug Administration (FDA) for Tabelecleucel Biologic License Application (BLA) - PR Newswire

Tue, 03 Mar 2026 08:00:00 GMT

Pierre Fabre Pharmaceuticals Submits Type A Meeting Request to U.S. Food and Drug Administration (FDA) for Tabelecleucel Biologic License Application (BLA) PR Newswire

Citius Pharmaceuticals, Inc. Announces First Reported Revenue Following Successful Launch of LYMPHIR™ - PR Newswire

Fri, 13 Feb 2026 08:00:00 GMT

Citius Pharmaceuticals, Inc. Announces First Reported Revenue Following Successful Launch of LYMPHIR™ PR Newswire

Is Regeneron Pharmaceuticals (REGN) Among the Best Biotech Stocks to Invest In According to Billionaire Steve Cohen? - Yahoo Finance

Mon, 11 May 2026 07:00:00 GMT

Is Regeneron Pharmaceuticals (REGN) Among the Best Biotech Stocks to Invest In According to Billionaire Steve Cohen? Yahoo Finance

Recursion Pharmaceuticals (RXRX): Best AI Stocks Under $50 to Buy Right Now - Yahoo Finance

Thu, 07 May 2026 07:00:00 GMT

Recursion Pharmaceuticals (RXRX): Best AI Stocks Under $50 to Buy Right Now Yahoo Finance

Catalyst Pharmaceutics to Report Q1 Earnings: Is a Beat in the Cards? - Zacks Investment Research

Mon, 04 May 2026 07:00:00 GMT

Catalyst Pharmaceutics to Report Q1 Earnings: Is a Beat in the Cards? Zacks Investment Research

Acadia Pharmaceuticals Rings the Opening Bell - Nasdaq

Mon, 16 Mar 2026 07:00:00 GMT

Acadia Pharmaceuticals Rings the Opening Bell Nasdaq

Merck to buy Terns Pharmaceuticals in $6.7B deal - statnews.com

Wed, 25 Mar 2026 07:00:00 GMT

Merck to buy Terns Pharmaceuticals in $6.7B deal statnews.com

Vanda Pharmaceuticals Announces FDA Approval of BYSANTI™ (milsaperidone) for the treatment of Bipolar I Disorder and Schizophrenia - A New Chemical Entity Opening New Horizons in Psychiatric Innovation - PR Newswire

Fri, 20 Feb 2026 08:00:00 GMT

Vanda Pharmaceuticals Announces FDA Approval of BYSANTI™ (milsaperidone) for the treatment of Bipolar I Disorder and Schizophrenia - A New Chemical Entity Opening New Horizons in Psychiatric Innovation PR Newswire

Alebund Pharmaceuticals Announces License and Equity Agreements With R1 Therapeutics - Cooley

Tue, 17 Mar 2026 07:00:00 GMT

Alebund Pharmaceuticals Announces License and Equity Agreements With R1 Therapeutics Cooley

Press release titled: “Kadimastem and NLS Pharmaceutics Announce Effectiveness of SEC Registration Statement in Connection with Proposed Merger.” - SEC.gov

Wed, 10 Sep 2025 18:36:28 GMT

Press release titled: “Kadimastem and NLS Pharmaceutics Announce Effectiveness of SEC Registration Statement in Connection with Proposed Merger.” SEC.gov

Akin Advises Pharmakon in $100 Million Debt Financing for Paratek Pharmaceuticals and Radius Health Combination - Akin

Thu, 19 Mar 2026 07:00:00 GMT

Akin Advises Pharmakon in $100 Million Debt Financing for Paratek Pharmaceuticals and Radius Health Combination Akin

Pharmaceuticals face 100% tariffs in US - unless they have a deal - BBC

Thu, 02 Apr 2026 07:00:00 GMT

Pharmaceuticals face 100% tariffs in US - unless they have a deal BBC

Mirum Pharmaceuticals Announces Primary Endpoint Met in VISTAS Study of Volixibat in Patients with Primary Sclerosing Cholangitis - Business Wire

Mon, 04 May 2026 07:00:00 GMT

Mirum Pharmaceuticals Announces Primary Endpoint Met in VISTAS Study of Volixibat in Patients with Primary Sclerosing Cholangitis Business Wire

AstraZeneca enhances its weight management portfolio through collaboration agreement with CSPC Pharmaceuticals - AstraZeneca

Fri, 30 Jan 2026 08:00:00 GMT

AstraZeneca enhances its weight management portfolio through collaboration agreement with CSPC Pharmaceuticals AstraZeneca

Cosmo Pharmaceuticals Reports Positive 12-Month Safety Data for Clascoterone 5% in Male AGA - Dermatology Times

Thu, 16 Apr 2026 07:00:00 GMT

Cosmo Pharmaceuticals Reports Positive 12-Month Safety Data for Clascoterone 5% in Male AGA Dermatology Times

Teva Pharmaceuticals CEO on acquiring Emalex Biosciences, drug portfolio - CNBC

Wed, 29 Apr 2026 07:00:00 GMT

Teva Pharmaceuticals CEO on acquiring Emalex Biosciences, drug portfolio CNBC

Vanda Pharmaceuticals Announces FDA Acceptance of Biologics License Application Filing for Imsidolimab for the Treatment of Generalized Pustular Psoriasis - PR Newswire

Wed, 25 Feb 2026 08:00:00 GMT

Vanda Pharmaceuticals Announces FDA Acceptance of Biologics License Application Filing for Imsidolimab for the Treatment of Generalized Pustular Psoriasis PR Newswire

Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE® - GlobeNewswire

Thu, 19 Mar 2026 07:00:00 GMT

Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE® GlobeNewswire

Tissue Dynamics and Galmed Pharmaceuticals to Develop Human-Centered Chronic Cardiac Fibrosis Platform to Advance Aramchol-Based Therapeutics - PR Newswire

Wed, 06 May 2026 07:00:00 GMT

Tissue Dynamics and Galmed Pharmaceuticals to Develop Human-Centered Chronic Cardiac Fibrosis Platform to Advance Aramchol-Based Therapeutics PR Newswire

Qubit Pharmaceuticals to Collaborate with the Centre for Quantum Technologies in Singapore to Advance Quantum Algorithms for Drug Discovery - The Quantum Insider

Thu, 30 Apr 2026 07:00:00 GMT

Qubit Pharmaceuticals to Collaborate with the Centre for Quantum Technologies in Singapore to Advance Quantum Algorithms for Drug Discovery The Quantum Insider

Arrowhead Pharmaceuticals to Participate in Upcoming June 2026 Events - Business Wire

Tue, 02 Jun 2026 07:00:00 GMT

Arrowhead Pharmaceuticals to Participate in Upcoming June 2026 Events Business Wire

Island Pharmaceuticals Expands USAMRIID Agreement for Galidesivir Marburg Study - smallcaps.com.au

Wed, 10 Jun 2026 03:57:31 GMT

Island Pharmaceuticals Expands USAMRIID Agreement for Galidesivir Marburg Study smallcaps.com.au

Merck to buy Terns Pharmaceuticals for $6.7 billion to boost cancer pipeline - CNBC

Wed, 25 Mar 2026 07:00:00 GMT

Merck to buy Terns Pharmaceuticals for $6.7 billion to boost cancer pipeline CNBC

Afinum Invests in Formulation Development Specialist ProJect Pharmaceutics - orrick.com

Tue, 23 Sep 2025 07:00:00 GMT

Afinum Invests in Formulation Development Specialist ProJect Pharmaceutics orrick.com

Ionic Liquids in Pharmaceuticals: A Scoping Review of Formulation Strategies - ACS Publications

Thu, 01 Jan 2026 12:00:11 GMT

Ionic Liquids in Pharmaceuticals: A Scoping Review of Formulation Strategies ACS Publications

Newron Pharmaceuticals to Participate in June Investor Conferences - Business Wire

Thu, 28 May 2026 07:00:00 GMT

Newron Pharmaceuticals to Participate in June Investor Conferences Business Wire

Arrowhead Pharmaceuticals Presents New Positive Clinical Cardiometabolic Data at the 94th European Atherosclerosis Society (EAS) Congress - Business Wire

Tue, 26 May 2026 07:00:00 GMT

Arrowhead Pharmaceuticals Presents New Positive Clinical Cardiometabolic Data at the 94th European Atherosclerosis Society (EAS) Congress Business Wire

Insider Sell: John Lamattina Sells Shares of Ligand Pharmaceuticals Inc (LGND) - GuruFocus

Sat, 13 Jun 2026 01:21:51 GMT

Insider Sell: John Lamattina Sells Shares of Ligand Pharmaceuticals Inc (LGND) GuruFocus

Cosette Pharmaceuticals Appoints David Bell as Chief Commercial Officer (Brands) - Business Wire

Tue, 19 May 2026 07:00:00 GMT

Cosette Pharmaceuticals Appoints David Bell as Chief Commercial Officer (Brands) Business Wire

Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2025 Financial Results and Provides 2026 Financial Guidance - PR Newswire

Tue, 24 Feb 2026 08:00:00 GMT

Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2025 Financial Results and Provides 2026 Financial Guidance PR Newswire